Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

NCT00127803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Infections

Interventions

BIOLOGICAL: Placebo (vaccine diluent)
BIOLOGICAL: Clostridium difficile vaccine
BIOLOGICAL: Clostridium difficile vaccine
BIOLOGICAL: Clostridium difficile vaccine

Sponsor

Sanofi